Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vita Life Sciences Limited ( (AU:VLS) ) has issued an update.
Vita Life Sciences Limited has announced an update regarding its ongoing on-market buy-back program, with a total of 29,959 ordinary fully paid securities bought back on the previous day, adding to the cumulative total of 477,454 securities repurchased before that day. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on the development and distribution of vitamins and supplements. The company is known for its commitment to enhancing health and well-being through innovative products.
Average Trading Volume: 14,723
Technical Sentiment Signal: Buy
Current Market Cap: A$131.4M
For detailed information about VLS stock, go to TipRanks’ Stock Analysis page.